What is ADC

Future cancer and other infectious disease treatments require a new type of cargo that precisely delivers the medicine to its specific target without causing undesired side-effects on healthy cells and tissue. This concept is fully demonstrated by antibody-drug conjugates, or ADCs, which combines the accurate targeting feature of a monoclonal antibody with highly cytotoxic payloads to achieve the strike of the lesion site as a precision-guided munition. https://www.creative-biolabs.com/adc/